( NYSE:ALR, NYSE:ALR.PRB )

News from Alere Inc. A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

Oct 02, 2017, 07:00 ET Alere Receives FDA Clearance for Alere™ i Influenza A & B 2 Rapid Molecular Test

Alere Inc. (NYSE: ALR), a global leader in rapid diagnostics, today announced that its Alere™ i Influenza A & B 2 test has received 510(k)...


Sep 29, 2017, 12:12 ET Alere Announces the U.S. Department of Justice Closes Investigation

Alere Inc. (NYSE: ALR) (the "Company"), a global leader in rapid diagnostic tests, today announced the U.S. Department of Justice (the "DOJ") has...


Sep 29, 2017, 09:26 ET Abbott Acquisition of Alere Set to Close on October 3, 2017

Alere Inc. (NYSE: ALR) announced today that Abbott's acquisition of Alere is intended to close on October 3, 2017. The announcement follows...


Sep 28, 2017, 21:37 ET Alere Announces Agreement in Principle to Settle with the U.S. Department of Justice

Alere Inc. (NYSE: ALR) (the "Company"), a global leader in rapid diagnostic tests, today announced that it has reached an agreement in principle to...


Sep 28, 2017, 11:50 ET Alere Announces Settlement with SEC

Alere Inc. (NYSE: ALR) (the "Company"), a global leader in rapid diagnostic tests, today announced that it has reached a settlement with the...


Sep 18, 2017, 20:27 ET Alere Announces Intent to Voluntarily Delist Series B Convertible Perpetual Preferred Stock from the NYSE Conditioned Upon the Completion of its Acquisition by Abbott

Alere Inc. (NYSE: ALR) ("Alere"), today announced that it has submitted written notice to the New York Stock Exchange (the "NYSE") of its intention...


Sep 18, 2017, 20:22 ET Alere Inc. Declares Cash Dividend on its Series B Convertible Perpetual Preferred Stock

Alere Inc. (NYSE: ALR), a global leader in rapid diagnostics, has declared a cash dividend of $3.00 per share on its Series B Convertible Perpetual...


Aug 11, 2017, 07:00 ET Alere Provides Notice to Holders of Series B Convertible Perpetual Preferred Stock

Alere Inc. (NYSE: ALR) ("Alere" or the "Company"), a global leader in rapid diagnostic tests, today is announcing the following, and will also be...


Aug 03, 2017, 06:41 ET Alere Reports Second Quarter 2017 Financial Results

Alere Inc. (NYSE: ALR), a global leader in rapid diagnostic tests, today announced its financial results for the second quarter ended June 30,...


Jul 31, 2017, 07:00 ET Immunalysis Receives FDA Clearance for SEFRIA™ Fentanyl Urine Drug Screening Test

Immunalysis Corporation, a division of Alere Inc. (NYSE: ALR), today announced that its SEFRIA™ Fentanyl Urine Enzyme Immunoassay has been granted...


Jul 19, 2017, 07:00 ET Alere Launches Alere iCup® Rx Drug Screen for Detecting Commonly Misused and Abused Prescription Drugs

Alere Inc. (NYSE: ALR), a global leader in rapid diagnostics, today announced the availability of its point-of-care Alere iCup® Rx Drug Screen, a...


Jul 07, 2017, 16:15 ET Alere Shareholders Approve Amended Merger with Abbott

Alere Inc. (NYSE: ALR) (the "Company"), a global leader in rapid diagnostic tests, today announced that its shareholders have voted to approve the...


Jun 23, 2017, 16:15 ET Alere Inc. Declares Cash Dividend on its Series B Convertible Perpetual Preferred Stock

Alere Inc. (NYSE: ALR), a global leader in rapid diagnostics, has declared a cash dividend of $3.00 per share on its Series B Convertible Perpetual...


Jun 14, 2017, 16:15 ET Alere Reports First Quarter 2017 Financial Results

Alere Inc. (NYSE: ALR), a global leader in rapid diagnostic tests, today announced its financial results for the first quarter ended March 31,...


Jun 05, 2017, 16:55 ET Alere Inc. Announces Termination of Consent Solicitations for Alere Inc.'s Notes and Offers Consent Termination Fee

Alere Inc. (NYSE: ALR) (the "Company") announced today the termination of the previously announced consent solicitations relating to the Company's...


Jun 05, 2017, 16:39 ET Alere Files Form 10-K, Reports Fourth Quarter and Full Year 2016 Financial Results

Alere Inc. (NYSE: ALR), a global leader in rapid diagnostic tests, today announced that it has filed its Form 10-K and reported its financial...


Jun 01, 2017, 08:38 ET Alere Inc. Announces Commencement of Additional Consent Solicitations for Alere Inc.'s Notes

Alere Inc. (NYSE: ALR) (the "Company") announced today the commencement of additional consent solicitations relating to the Company's 6.500% Senior...


May 22, 2017, 09:15 ET Alere Announces Update on Form 10-K and Provides Preliminary Unaudited Financial Results

Alere Inc. (NYSE: ALR), a global leader in rapid diagnostic tests, today announced certain preliminary unaudited financial information for the...


May 08, 2017, 16:15 ET Alere Inc. Announces Successful Completion of Consent Solicitations for Alere Inc.'s Notes

Alere Inc. (NYSE: ALR) (the "Company") announced today the successful completion of the previously announced consent solicitations relating to the...


May 04, 2017, 07:00 ET Alere Inc. Announces Modifications of Consent Solicitations for Alere Inc.'s Notes

Alere Inc. (NYSE: ALR) (the "Company") announced today certain modifications to the previously announced consent solicitations relating to the...


May 01, 2017, 07:00 ET Alere Inc. Announces Commencement of Consent Solicitations for Alere Inc.'s Notes

Alere Inc. (NYSE: ALR) (the "Company") announced today the commencement of consent solicitations relating to the Company's 6.500% Senior...


Apr 25, 2017, 07:00 ET Alere Launches the Alere™ Malaria Ag P.f, the First-Ever Rapid Test to Screen Malaria Infection in Asymptomatic Individuals

Alere Inc. (NYSE: ALR), a global leader in rapid diagnostics, today announced the launch of its Alere™ Malaria Ag P.f, a major technological...


Apr 11, 2017, 07:00 ET Alere Achieves FDA Clearance for Alere™ Reader Platform and Alere BinaxNOW® Influenza A & B Card 2

Alere Inc. (NYSE: ALR), a global leader in rapid diagnostics, today announced that its Alere™ Reader, a diagnostic analyzer that can be used in...


Mar 21, 2017, 17:16 ET Alere Inc. Receives NYSE Notice Regarding Late Form 10-K Filing

Alere Inc. (NYSE: ALR) (the "Company") announced today that, as a result of its failure to timely file its Annual Report on Form 10-K for...


Mar 20, 2017, 16:30 ET Alere Inc. Declares Cash Dividend on its Series B Convertible Perpetual Preferred Stock

Alere Inc. (NYSE: ALR), a global leader in rapid diagnostics, has declared a cash dividend of $3.00 per share on its Series B Convertible Perpetual...